Daniel Truong, MD, medical director and founder of The Parkinson's and Movement Disorder Institute, located on the campus of MemorialCare Orange Coast Medical Center, was recently re-elected president of The International Association of Parkinsonism and Related Disorders (IAPRD) at the XXIV World Congress on Parkinson’s Disease and Related Disorders in Montreal, Canada. During his previous 4-year term as president, Dr. Truong changed the Biannual World Congress in Parkinsonism and Related Disorders to an annual event. In his next presidential term, Dr. Truong will focus his efforts on expanding the association’s membership to include neurosurgeons, psychiatrists and allied health professionals.
Sixty years ago, The International Association of Parkinsonism and Related Disorders was established by the World Federation of Neurology Research Group to promote and monitor research developments, as well as to foster communication among neuroscientists in the field. Today, the association is an international, professional association of clinicians, scientists and other healthcare professionals who are interested in neurodegenerative disorders like Parkinson‘s disease, secondary Parkinsonism, hyperkinetic and hypokinetic movement disorders, and more generally any disorder affecting muscle tone and motor control. The IAPRD comprises of associate members, full members, and honorary members.
“I am honored and humbled to be elected IAPRD’s president,” said Dr. Truong. “Together, my fellow members and I can continue to maximize this international platform to engage in productive discussions and lively debates about the latest clinical research efforts, findings, and initiatives that can hopefully bring us one step closer to improving the lives of those patients afflicted by Parkinson’s and movement disorders.”
Dr. Truong is known internationally for his work in developing the animal model of myoclonus for which he received the Franz Burda award from Austria. The model has become the mainstay for research in this field. The Truong and Fahn myoclonus rating scale, which was developed by both Drs. Truong and Stanley Fahn, has evolved into the Unified Myoclonus Rating scale as primary instruments used internationally for therapeutic investigation of the disease. Dr. Truong also helped spearhead the early of development of botulinum toxin use in spasmodic dysphonia, a disorder that renders the patient unable to talk.
Dr. Truong has conducted extensive research in Parkinson disease is the author and co-author of over 160 scientific articles and book chapters. He has published 6 books, one of them has been translated to many languages and has lectured in over 20 countries. Dr. Truong is the editor in chief of the journal Clinical Parkinsonism and Related Disorders and serves associate editor for various medical Journals. He was the founder of the National Spasmodic Dysphonia Association (NSDA), for which he served as chairman of the medical advisory board from 1990 to 1997.
For information about The Parkinson's & Movement Disorder Medical Group, please call (714) 378-5062 or log on to www.pmdi.org.